Login
Subscribe
New Synthetic E. coli Is Immune to Bacteriophage Infection
New Synthetic E. coli Is Immune to Bacteriophage Infection
Self-contained synthetic E. coli resistant to viral infection could prove invaluable to the biotechnology industry by increasing product consistency and reducing safety concerns.
Self-contained synthetic E. coli resistant to viral infection could prove invaluable to the biotechnology industry by increasing product consistency and reducing safety concerns.
synthetic biology, immunology
“Smarter” CAR T Cells Target Tumors with Precision
Natalia Mesa, PhD | Dec 16, 2022 | 5 min read
Two studies in mice now show that researchers can control when and where CAR T cells are active, potentially overcoming previous hurdles for CAR T–based treatments.
The Scientist Speaks - Repurposing Living Systems to Fight a Pandemic
The Scientist | Sep 29, 2020 | 1 min read
Episode 9
Researchers Build a Cancer Immunotherapy Without Immune Cells
Abby Olena, PhD | Nov 13, 2017 | 3 min read
A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro.
Contributors
Catherine Offord | Jun 1, 2016 | 3 min read
Meet some of the people featured in the June 2016 issue of The Scientist.